Children who take medication to treat attention deficit hyperactivity disorder (ADHD) face no greater risk of future substance abuse, finds the latest study to test a theory that stimulants used to treat the disorder “sensitize” children to various types of drugs, paving the way for subsequent use.
Researchers say this study, published in the January issue of Pediatrics, is now the eleventh to find no evidence of the so-called “sensitization theory,” suggesting that children treated with ADHD medications such as methylphenidate (Ritalin) , d-amphetamine (Adderall), and pemoline (Sylert) are more likely to smoke, drink, or take illicit drugs as teenagers or adults. Only one study documented an increased risk of later cocaine use among children who have been treated with these stimulants, which bring improvement in about 80% of children with ADHD.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!